Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedApr 15, 2025
DataAggregated Company Financials
Companies39
- 7D11.7%
- 3M21.2%
- 1Y15.3%
- YTD16.3%
Over the last 7 days, the Pharma industry has dropped 6.2%, driven by Tianda Pharmaceuticals declining 19%. In contrast, Hansoh Pharmaceutical Group has gained 10%. In the past year, the industry has gained 11%. Looking forward, earnings are forecast to grow by 12% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 15 Apr 2025 | HK$486.6b | HK$465.4b | HK$28.5b | 10.2x | 17.1x | 1x |
| Thu, 13 Mar 2025 | HK$453.0b | HK$463.7b | HK$31.9b | 8.7x | 14.2x | 1x |
| Sat, 08 Feb 2025 | HK$421.8b | HK$462.0b | HK$31.9b | 8.7x | 13.2x | 0.9x |
| Mon, 06 Jan 2025 | HK$417.9b | HK$459.5b | HK$31.7b | 8.5x | 13.2x | 0.9x |
| Wed, 04 Dec 2024 | HK$450.8b | HK$461.8b | HK$31.8b | 8.3x | 14.2x | 1x |
| Fri, 01 Nov 2024 | HK$459.4b | HK$471.3b | HK$32.7b | 8.2x | 14.1x | 1x |
| Sun, 29 Sep 2024 | HK$484.3b | HK$478.0b | HK$33.2b | 7.9x | 14.6x | 1x |
| Tue, 27 Aug 2024 | HK$426.6b | HK$466.1b | HK$31.1b | 6.9x | 13.7x | 0.9x |
| Thu, 25 Jul 2024 | HK$421.7b | HK$457.4b | HK$32.5b | 7.5x | 13x | 0.9x |
| Sat, 22 Jun 2024 | HK$447.0b | HK$461.9b | HK$33.8b | 7.8x | 13.2x | 1x |
| Mon, 20 May 2024 | HK$487.2b | HK$463.6b | HK$33.8b | 8.8x | 14.4x | 1.1x |
| Wed, 17 Apr 2024 | HK$437.6b | HK$464.7b | HK$33.8b | 7.5x | 12.9x | 0.9x |
| Fri, 15 Mar 2024 | HK$465.5b | HK$470.8b | HK$33.5b | 7.7x | 13.9x | 1x |
| Sun, 11 Feb 2024 | HK$410.1b | HK$471.8b | HK$33.7b | 6.6x | 12.2x | 0.9x |
| Tue, 09 Jan 2024 | HK$460.0b | HK$472.0b | HK$33.7b | 7.7x | 13.6x | 1x |
| Thu, 07 Dec 2023 | HK$487.1b | HK$472.1b | HK$33.7b | 7.5x | 14.4x | 1x |
| Sat, 04 Nov 2023 | HK$489.4b | HK$469.0b | HK$31.9b | 6.9x | 15.4x | 1x |
| Mon, 02 Oct 2023 | HK$436.3b | HK$469.5b | HK$31.6b | 6.8x | 13.8x | 0.9x |
| Wed, 30 Aug 2023 | HK$439.8b | HK$449.3b | HK$30.1b | 7.8x | 14.6x | 1x |
| Fri, 28 Jul 2023 | HK$489.7b | HK$447.1b | HK$27.9b | 9.4x | 17.5x | 1.1x |
| Sun, 25 Jun 2023 | HK$481.3b | HK$447.0b | HK$27.7b | 9.6x | 17.4x | 1.1x |
| Tue, 23 May 2023 | HK$503.7b | HK$450.1b | HK$28.1b | 8.9x | 17.9x | 1.1x |
| Thu, 20 Apr 2023 | HK$574.6b | HK$453.4b | HK$28.8b | 9.2x | 20x | 1.3x |
| Sat, 18 Mar 2023 | HK$607.9b | HK$444.4b | HK$34.3b | 10.6x | 17.7x | 1.4x |
| Mon, 13 Feb 2023 | HK$614.6b | HK$447.1b | HK$35.6b | 11x | 17.3x | 1.4x |
| Wed, 11 Jan 2023 | HK$634.6b | HK$446.9b | HK$35.5b | 11.7x | 17.9x | 1.4x |
| Fri, 09 Dec 2022 | HK$614.2b | HK$441.6b | HK$34.7b | 10.7x | 17.7x | 1.4x |
| Sun, 06 Nov 2022 | HK$578.4b | HK$434.0b | HK$33.5b | 9x | 17.3x | 1.3x |
| Tue, 04 Oct 2022 | HK$501.6b | HK$514.3b | HK$40.0b | 8.8x | 12.5x | 1x |
| Thu, 01 Sep 2022 | HK$565.7b | HK$520.3b | HK$41.6b | 9.9x | 13.6x | 1.1x |
| Sat, 30 Jul 2022 | HK$596.3b | HK$513.0b | HK$51.9b | 8.1x | 11.5x | 1.2x |
| Mon, 27 Jun 2022 | HK$631.1b | HK$514.9b | HK$52.0b | 9.5x | 12.1x | 1.2x |
| Wed, 25 May 2022 | HK$575.1b | HK$515.1b | HK$52.3b | 8.7x | 11x | 1.1x |
| Fri, 22 Apr 2022 | HK$579.1b | HK$523.2b | HK$52.6b | 8.3x | 11x | 1.1x |
Price to Earnings Ratio
11x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 16.5x which is higher than its 3-year average PE of 14.5x.
- The industry is trading close to its 3-year average PS ratio of 1.1x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have declined 18% per year over the last three years,
- Revenues have also declined 3.8% per year.
- This means overall sales from these companies are declining and profits are subsequently falling as well.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 8.17% | |
| Healthcare | 14.77% | |
| Pharma | 11.71% | |
| Pharma | 11.71% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1093 CSPC Pharmaceutical Group | HK$5.60 | 14.5% +HK$8.1b | -3.6% | PE14x | |
| 1177 Sino Biopharmaceutical | HK$3.72 | 8.8% +HK$5.4b | 46.5% | PE32.7x | |
| 3692 Hansoh Pharmaceutical Group | HK$22.15 | 3.3% +HK$4.2b | 40.5% | PE28.3x | |
| 3933 United Laboratories International Holdings | HK$13.38 | 10.8% +HK$2.4b | 38.5% | PE8.6x | |
| 1558 YiChang HEC ChangJiang Pharmaceutical | HK$11.50 | 27.8% +HK$2.2b | -9.6% | PE19.7x |